home All News open_in_new Full Article
AstraZeneca informa una rebaja del 44% en el avance del cáncer de mama con su fármaco Enhertu
today 5 d. ago attach_file Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
ID: 2478675294